Ad is loading...
BRSVX
Price
$43.64
Change
+$0.70 (+1.63%)
Updated
Nov 22 closing price
VISVX
Price
$51.30
Change
+$0.69 (+1.36%)
Updated
Nov 22 closing price
Ad is loading...

BRSVX vs VISVX

Header iconBRSVX vs VISVX Comparison
Open Charts BRSVX vs VISVXBanner chart's image
Bridgeway Small-Cap Value
Price$43.64
Change+$0.70 (+1.63%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$51.30
Change+$0.69 (+1.36%)
VolumeN/A
CapitalizationN/A
BRSVX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BRSVX vs. VISVX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRSVX is a Buy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. BRSVX (521M). VISVX pays higher dividends than BRSVX: VISVX (1.90) vs BRSVX (0.90). BRSVX was incepted earlier than VISVX: BRSVX (21 years) vs VISVX (27 years). BRSVX is a more actively managed with annual turnover of: 61.00 vs. VISVX (16.00). BRSVX has a lower initial minimum investment than VISVX: BRSVX (2000) vs VISVX (3000). VISVX annual gain was more profitable for investors over the last year : 30.04 vs. BRSVX (21.81). BRSVX return over 5 years is better than : 112.95 vs. VISVX (62.14).
BRSVXVISVXBRSVX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years27 years-
Gain YTD9.91217.71256%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets521M57.6B1%
Annual Yield % from dividends0.901.9047%
Returns for 1 year21.8130.0473%
Returns for 3 years8.3116.9249%
Returns for 5 years112.9562.14182%
Returns for 10 years110.85109.83101%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EFXT9.240.20
+2.21%
Enerflex Ltd
RVSN0.440.01
+1.60%
Rail Vision Ltd
CAG27.170.05
+0.18%
Conagra Brands
FULC2.97-0.02
-0.67%
Fulcrum Therapeutics
KYMR43.51-0.54
-1.23%
Kymera Therapeutics